What is the status of Orbicular Pharmaceutical's generic Ozempic?

Orbicular Pharmaceutical has received tentative approval from the FDA for a generic version of Ozempic (semaglutide injection).

Who will market the generic semaglutide injection in the US?

Apotex Corp., the ANDA applicant, will market and commercialize the generic semaglutide injection in the United States.

What is the significance of this FDA tentative approval?

This approval marks a significant step in developing high-quality, affordable peptide therapies, requiring deep scientific rigor and advanced analytical precision.

Home / Health / Generic Ozempic Gets Green Light

Generic Ozempic Gets Green Light

11 Apr

•

Summary

Orbicular Pharmaceutical received tentative approval for generic Ozempic.
Apotex Corp. will market and sell the drug in the United States.
This achievement marks a significant step for complex peptide therapies.

Orbicular Pharmaceutical Technologies has achieved a significant milestone with the tentative approval of a generic semaglutide injection, commonly known as Ozempic. This development was realized through a partnership with Apotex, with Apotex Corp. set to handle the marketing and commercialization of the product in the United States.

Orbicular's Managing Director, M. S. Mohan, highlighted the scientific rigor required for complex peptide products and commended Apotex's regulatory leadership. Barry Fishman of Apotex emphasized Orbicular's scientific expertise and commitment to quality in advancing affordable peptide therapies for patients.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.